↓ Skip to main content

Blockchain technology for improving clinical research quality

Overview of attention for article published in Trials, July 2017
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • One of the highest-scoring outputs from this source (#8 of 3,811)
  • High Attention Score compared to outputs of the same age (98th percentile)

Mentioned by

news
11 news outlets
blogs
2 blogs
twitter
55 tweeters
googleplus
1 Google+ user

Citations

dimensions_citation
52 Dimensions

Readers on

mendeley
277 Mendeley
citeulike
3 CiteULike
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Blockchain technology for improving clinical research quality
Published in
Trials, July 2017
DOI 10.1186/s13063-017-2035-z
Pubmed ID
Authors

Mehdi Benchoufi, Philippe Ravaud

Abstract

Reproducibility, data sharing, personal data privacy concerns and patient enrolment in clinical trials are huge medical challenges for contemporary clinical research. A new technology, Blockchain, may be a key to addressing these challenges and should draw the attention of the whole clinical research community.Blockchain brings the Internet to its definitive decentralisation goal. The core principle of Blockchain is that any service relying on trusted third parties can be built in a transparent, decentralised, secure "trustless" manner at the top of the Blockchain (in fact, there is trust, but it is hardcoded in the Blockchain protocol via a complex cryptographic algorithm). Therefore, users have a high degree of control over and autonomy and trust of the data and its integrity. Blockchain allows for reaching a substantial level of historicity and inviolability of data for the whole document flow in a clinical trial. Hence, it ensures traceability, prevents a posteriori reconstruction and allows for securely automating the clinical trial through what are called Smart Contracts. At the same time, the technology ensures fine-grained control of the data, its security and its shareable parameters, for a single patient or group of patients or clinical trial stakeholders.In this commentary article, we explore the core functionalities of Blockchain applied to clinical trials and we illustrate concretely its general principle in the context of consent to a trial protocol. Trying to figure out the potential impact of Blockchain implementations in the setting of clinical trials will shed new light on how modern clinical trial methods could evolve and benefit from Blockchain technologies in order to tackle the aforementioned challenges.

Twitter Demographics

The data shown below were collected from the profiles of 55 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 277 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 277 100%

Demographic breakdown

Readers by professional status Count As %
Student > Master 70 25%
Researcher 42 15%
Student > Ph. D. Student 37 13%
Student > Bachelor 28 10%
Other 14 5%
Other 47 17%
Unknown 39 14%
Readers by discipline Count As %
Computer Science 75 27%
Medicine and Dentistry 36 13%
Business, Management and Accounting 30 11%
Engineering 20 7%
Biochemistry, Genetics and Molecular Biology 7 3%
Other 51 18%
Unknown 58 21%

Attention Score in Context

This research output has an Altmetric Attention Score of 147. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 01 November 2019.
All research outputs
#114,710
of 14,535,614 outputs
Outputs from Trials
#8
of 3,811 outputs
Outputs of similar age
#4,781
of 267,344 outputs
Outputs of similar age from Trials
#1
of 1 outputs
Altmetric has tracked 14,535,614 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 99th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 3,811 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 7.7. This one has done particularly well, scoring higher than 99% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 267,344 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 98% of its contemporaries.
We're also able to compare this research output to 1 others from the same source and published within six weeks on either side of this one. This one has scored higher than all of them